SciELO - Scientific Electronic Library Online

 
vol.111 issue6Quarantine alone or in combination with other public health measures to control COVID-19: A rapid Cochrane reviewHIV and SARS-CoV-2 co-infection: The diagnostic challenges of dual pandemics author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

    Related links

    • On index processCited by Google
    • On index processSimilars in Google

    Share


    SAMJ: South African Medical Journal

    On-line version ISSN 2078-5135Print version ISSN 0256-9574

    Abstract

    JACOBSON, B F  and  BEHALF OF THE SOUTHERN AFRICAN SOCIETY OF THROMBOSIS AND HAEMOSTASIS et al. Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia. SAMJ, S. Afr. med. j. [online]. 2021, vol.111, n.6, pp.535-537. ISSN 2078-5135.  https://doi.org/10.7196/SAMJ.2021.v111i6.157722.

    There have recently been safety concerns regarding an increased risk of vaccine-induced immune thrombotic thrombocytopenia (VITT) following administration of SARS-CoV-2 adenoviral vector vaccines. The Southern African Society of Thrombosis and Haemostasis reviewed the emerging literature on this idiosyncratic complication. A draft document was produced and revised by consensus agreement by a panel of professionals from various specialties. The recommendations were adjudicated by independent international experts to avoid local bias. We present concise, practical guidelines for the clinical management of VITT.

            · text in English     · English ( pdf )